IV Lidocaine Analgesia in Pediatric Scoliosis Surgery
Key facts
- Who runs it
- University of British Columbia
- Where
- Canada1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 3
- People taking part
- 48 people enrolled
- Started
- 18 Dec 2019
- Ended
- 10 May 2024
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Lidocaine
- Saline Solution
- Record updated
- 14 May 2024
Who can take part
- Age
- 10 years to 19 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- ASA I-III
- Diagnosed with Idiopathic scoliosis
- Undergoing single-stage posterior spinal instrumentation and fusion
Who cannot take part
- Pre-existing pain complaints, i.e. on regular analgesic medications
- Known allergy to lidocaine
- Known cardiac, renal or liver disease or dysfunction
- Current psychiatric diagnosis, e.g. anxiety, depression, eating disorder, defined according to DSM criteria
- Any history of seizures
- Weight < 5th centile or > 85th centile for age
- Thorascopic tethering procedure
- Two-stage procedure
- Abnormal developmental profile
- Congenital/neuromuscular scoliosis
- Requiring PICU admission
- Requiring non-standard post-op pain management
- Unplanned staged procedure
- Porphyria
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Surgical correction of scoliosis in children is a long procedure, with an equivalently long recovery time, that is commonly performed at BC Children's Hospital. Treating pain immediately after the procedure is a priority for children during recovery. Morphine is one medication that can be used to manage post-operative pain, but unfortunately, its use is accompanied by a number of side effects which can affect recovery. These include nausea, vomiting, pruritus, sedation, dysphoria, respiratory depression, constipation, ileus, and urinary retention.
Read full original descriptionShow less
In order to control pain and reduce morphine consumption, intravenous lidocaine is being investigated. This therapy has been beneficial in adult populations undergoing abdominal surgery and has been associated with decreased post-operative pain, decrease use of opioids including morphine, and ileus. These all contribute to shorter lengths of stay in the hospital and better recovery in the adult population.
Intravenous lidocaine is used by some anesthesiologists at BC Children's Hospital to manage post-operative pain in children receiving surgical correction for scoliosis, but this is not a standard of practice. We now propose to conduct a double-blind randomized controlled trial to determine if intravenous lidocaine, infused from start of anesthesia up to 48 hours post-operatively, will reduce morphine use and improve post-operative pain in the pediatric population.
The 2 groups in the trial
- Intravenous lidocaineTreatment being tested
1% preservative free lidocaine 10 mg/ml in 0.9% NaCl
Treatment: Lidocaine
- Intravenous saline controlPlacebo, for comparison
0.9% sodium chloride, also known as normal saline
Treatment: Saline Solution
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Perioperative Multimodal Analgesia Including Intravenous Lidocaine Infusion for Pain Management Following Idiopathic Scoliosis Correction Surgery in Children
- Publications
- Record updated
- 14 May 2024